{"transactions":[{"id":2669790,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T16:56:26.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":3285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders."}],"balance_after":44999,"source":{"system":"sec-edgar","filing":"0001562180-21-004244","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218021004244/primarydocument.xml","form_type":"4"}},{"id":2953129,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-08T16:51:03.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":25777,"price":37.1863,"value":958551.2551,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.44 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41714,"source":{"system":"sec-edgar","filing":"0001562180-20-007110","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020007110/primarydocument.xml","form_type":"4"}},{"id":3010680,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-07T18:51:59.000Z","date":"2020-10-02","kind":"sale","acquired":false,"shares":1700,"price":37.01,"value":62917.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.03 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":67491,"source":{"system":"sec-edgar","filing":"0001562180-20-006319","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020006319/primarydocument.xml","form_type":"4"}},{"id":3015646,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T16:53:44.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":423,"price":37.0015,"value":15651.6345,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.01 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":69191,"source":{"system":"sec-edgar","filing":"0001562180-20-006234","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020006234/primarydocument.xml","form_type":"4"}},{"id":3073874,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T17:33:24.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":400,"price":37,"value":14800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1."}],"balance_after":69614,"source":{"system":"sec-edgar","filing":"0001562180-20-005227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020005227/primarydocument.xml","form_type":"4"}},{"id":3073873,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T17:33:24.000Z","date":"2020-07-27","kind":"sale","acquired":false,"shares":1700,"price":37.0141,"value":62923.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 12, 2019, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $37.00 to $37.02 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70014,"source":{"system":"sec-edgar","filing":"0001562180-20-005227","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020005227/primarydocument.xml","form_type":"4"}},{"id":3106535,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-17T19:20:28.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":5443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders."}],"balance_after":71714,"source":{"system":"sec-edgar","filing":"0001562180-20-004565","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020004565/primarydocument.xml","form_type":"4"}},{"id":3258984,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-20T19:05:35.000Z","date":"2020-02-14","kind":"other","acquired":true,"shares":29482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution for no consideration."}],"balance_after":66271,"source":{"system":"sec-edgar","filing":"0001562180-20-001417","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020001417/primarydocument.xml","form_type":"4"}},{"id":3258983,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-20T19:05:35.000Z","date":"2020-02-14","kind":"other","acquired":false,"shares":609143,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of these shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001417","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020001417/primarydocument.xml","form_type":"4"}},{"id":3284143,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-07T17:51:59.000Z","date":"2020-02-05","kind":"other","acquired":true,"shares":33232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares acquired by the Reporting Person pursuant to pro rata distributions for no consideration."}],"balance_after":36789,"source":{"system":"sec-edgar","filing":"0001562180-20-001027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020001027/primarydocument.xml","form_type":"4"}},{"id":3284142,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-07T17:51:59.000Z","date":"2020-02-05","kind":"other","acquired":false,"shares":609144,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":609143,"source":{"system":"sec-edgar","filing":"0001562180-20-001027","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218020001027/primarydocument.xml","form_type":"4"}},{"id":3424716,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-03T19:51:33.000Z","date":"2019-09-01","kind":"grant","acquired":true,"shares":3557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the \"2019 Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders."}],"balance_after":3557,"source":{"system":"sec-edgar","filing":"0001562180-19-004588","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000156218019004588/primarydocument.xml","form_type":"4"}},{"id":3454169,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Preferred Stock","published_at":"2019-07-29T21:01:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":235916,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":235916},"source":{"system":"sec-edgar","filing":"0001628280-19-009171","document":"wf-form4_156444845692930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828019009171/wf-form4_156444845692930.xml","form_type":"4"}},{"id":3454168,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-07-29T21:01:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":345591,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":345591},"source":{"system":"sec-edgar","filing":"0001628280-19-009171","document":"wf-form4_156444845692930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828019009171/wf-form4_156444845692930.xml","form_type":"4"}},{"id":3454167,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-07-29T21:01:14.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":636780,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":636780},"source":{"system":"sec-edgar","filing":"0001628280-19-009171","document":"wf-form4_156444845692930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828019009171/wf-form4_156444845692930.xml","form_type":"4"}},{"id":3454166,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T21:01:14.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":235916,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":1218287,"source":{"system":"sec-edgar","filing":"0001628280-19-009171","document":"wf-form4_156444845692930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828019009171/wf-form4_156444845692930.xml","form_type":"4"}},{"id":3454165,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T21:01:14.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":345591,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":982371,"source":{"system":"sec-edgar","filing":"0001628280-19-009171","document":"wf-form4_156444845692930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828019009171/wf-form4_156444845692930.xml","form_type":"4"}},{"id":3454164,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T21:01:14.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":636780,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of the shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein."}],"balance_after":636780,"source":{"system":"sec-edgar","filing":"0001628280-19-009171","document":"wf-form4_156444845692930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828019009171/wf-form4_156444845692930.xml","form_type":"4"}},{"id":3498510,"issuer":{"id":6423,"kind":"organization","name":"Huckleberry.ai, Inc.","symbol":"DOMO"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2019-06-06T21:34:32.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":4699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are represented by restricted stock units (\"RSU\"s).  Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule.  In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be cancelled by the issuer"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares are represented by restricted stock units (\"RSU\"s).  Each RSU represents the Reporting Person's right to receive one share of Class B Common Stock of the Issuer, subject to the applicable vesting schedule.  In the event the Reporting Person ceases to be a service provider, the unvested RSUs will be cancelled by the issuer"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"783 shares acquired as a zero-cost, pro rata distribution from Zetta Venture Partners I, L.P."}],"balance_after":25483,"source":{"system":"sec-edgar","filing":"0001628280-19-007679","document":"wf-form4_155987125635584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828019007679/wf-form4_155987125635584.xml","form_type":"4"}},{"id":3874220,"issuer":{"id":6423,"kind":"organization","name":"Huckleberry.ai, Inc.","symbol":"DOMO"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2018-07-03T20:18:14.000Z","date":"2018-07-03","kind":"exercise","acquired":false,"shares":70190,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":70190},"source":{"system":"sec-edgar","filing":"0001628280-18-009098","document":"wf-form4_153066347844675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828018009098/wf-form4_153066347844675.xml","form_type":"4"}},{"id":3874219,"issuer":{"id":6423,"kind":"organization","name":"Huckleberry.ai, Inc.","symbol":"DOMO"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-07-03T20:18:14.000Z","date":"2018-07-03","kind":"exercise","acquired":false,"shares":18783,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each of the Series A Preferred Stock and Series C Preferred Stock automatically converted into shares of Class B Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Class B Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":18783},"source":{"system":"sec-edgar","filing":"0001628280-18-009098","document":"wf-form4_153066347844675.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828018009098/wf-form4_153066347844675.xml","form_type":"4"}},{"id":3874218,"issuer":{"id":6423,"kind":"organization","name":"Huckleberry.ai, Inc.","symbol":"DOMO"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2018-07-03T20:18:14.000Z","date":"2018-07-03","kind":"exercise","acquired":true,"shares":70190,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein."}],"balance_after":97762,"source":{"system":"sec-edgar","filing":"0001628280-18-009098","document":"wf-form4_153066347844675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828018009098/wf-form4_153066347844675.xml","form_type":"4"}},{"id":3874217,"issuer":{"id":6423,"kind":"organization","name":"Huckleberry.ai, Inc.","symbol":"DOMO"},"owners":[{"id":138285,"kind":"person","name":"Bullock D Fraser","position":1,"cik":"0001366853","reported_name":"Bullock D Fraser","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2018-07-03T20:18:14.000Z","date":"2018-07-03","kind":"exercise","acquired":true,"shares":18783,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are held directly by the Bullock Family 2003 Gift Trust. Jennifer Bullock serves as trustee to the Bullock Family 2003 Gift Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 2003 Gift Trust except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by the Bullock Family 101 Trust. Robert Gardner serves as trustee to the Bullock Family 101 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Bullock Family 101 Trust except to the extent of any pecuniary interest therein."}],"balance_after":27572,"source":{"system":"sec-edgar","filing":"0001628280-18-009098","document":"wf-form4_153066347844675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1366853/000162828018009098/wf-form4_153066347844675.xml","form_type":"4"}}]}